Thanks, that makes sense Do you have any experience with pre commercial biotech option markets, like making markets around binary events like Phase 2 trial res

Thanks, that makes sense Do you have any experience with pre commercial biotech option markets, like making markets around binary events like Phase 2 trial results? I feel like the pricing of that volatility is quite inefficient but don't know enough about options math or market structure to really test that hypothesis